Leids Universitair Medisch Centrum ( Site 1503) — Leiden, South Holland

Public research footprint of Leids Universitair Medisch Centrum ( Site 1503), compiled from the ClinicalTrials.gov public registry.

233

Registered studies

101

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Atherosclerotic Cardiovascular Disease (ASCVD) · Relapsed/Refractory Small Cell Lung Cancer · Clostridium Difficile Infection Recurrence

Recently updated registry entries

NCT07554339 — A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell… (Recruiting)
NCT07742319 — How Differences in the Composition of Microorganisms in the Soil Affect the… (Not Yet Recruiting)
NCT05291091 — Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON) (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Leids Universitair Medisch Centrum ( Site 1503)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.